DOSSIER · 13F Holders · Q2 2026
Cartesian Therapeutics CVR
3 institutions still hold Cartesian Therapeutics CVR as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 816212112·3 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
3 institutions reported Cartesian Therapeutics CVR in Q2 2026. Sterling Capital Management LLC leads at 100.0% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.